Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

BARELY ADEQUATE: In Anavex terms, a $14B buyout would be ~ $150 per share.

That would be the amount barely adequate for the years of risk and frustration. I would not feel good until we hit $250 at least. That would be a fair amount for alz and Rett, but nothing else. If we really have got it and can get approved for multiples diseases like PD, autism, seizures, schizophrenia, cardio, glaucoma, then obviously the $1249 number sounds about right.